Monsenso and Empano partner up to help unemployed people get back into the labor force faster

Monsenso and Empano partner up to help unemployed people get back into the labor force faster

CoMonsenso and Empano partner up to help unemployed people coping with stress and depression get back into the labor force.

Monsenso enters a partnership with Empano, a private player in psychology and psychiatry services. Together, Monsenso and Empano offer a solution for the Danish municipalities to support unemployed people suffering with stress and depression in their return to work process. 

In a situation with historically high unemployment, we are pleased to offer a solution that can help get more Danes back into the labor force faster. It’s always difficult to be outside the labor force, and even more so if you suffer from stress and depression. Therefore, we are pleased to offer a solution to municipalities that can help unemployed people suffering with stress and depression get back to work” says CEO Thomas Lethenborg.. 

The municipalities are facing a major task due to the increased unemployment we are seeing in the wake of Covid-19. The combination of our services in the psychology and psychiatry services, and Monsenso’s platform to support follow-up and data collection is unique in the market and we are convinced that the service can help municipalities to proactively help the larger group of unemployed“says Director Camilla Stokholm Bjørkman from Empano.

Initially, the solution will be implemented in Guldborgssund Municipality in September 2020.

To read the Danish version, click here.

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

Reference
GOGREEN ROUTES Project Outline, click here.

Monsenso is expanding in the UK with a new Sales Office and hiring of Area Sales Manager

Monsenso is expanding in the UK with a new Sales Office and hiring of Area Sales Manager

Monsenso A/S is establishing an office in the UK to support the growth plan and is hiring Michelle Woolley as Area Sales Manager.

Monsenso, a technology leader in mobile health (mHealth) solutions for mental health is opening an office in London; Monsenso UK Ltd. to strengthen and support the expansion of the business in the UK, the company has hired Michelle Woolley as Area Sales Manager.

Michelle comes to Monsenso with a strong experience in sales management and business development from both Medtech and the pharmaceutical industry from i.e. Pfizer, 3M Healthcare, Servier, and Icentia

Michelle has a Microbiology degree BSc (Hons) from University of Bristol.

Michelle Woolley starts November 9, 2020.

With the opening of an office in the UK and the hiring of Michelle, we continue Monsenso’s international expansion in line with our growth strategy. Michelle will be an important addition to the team and we look forward to welcoming her”, says CEO Thomas Lethenborg.

Click on the link to read the press release in Danish.

For additional information, please contact:

Bettina van Wylich-Muxoll
Marketing
Monsenso
+45 22 70 47 24
marketing@monsenso.com

New partership to help unemployed people get back into the labor force faster.

New partership to help unemployed people get back into the labor force faster.

New partership to help unemployed people get back into the labor force faster. Monsenso enters a partnership with Empano, a private player in psychology and psychiatry services. Together, Monsenso and Empano offer a solution for the Danish municipalities to support unemployed people suffering with stress and depression in their return to work process. Initially, the solution will be implemented in Guldborgssund Municipality, Denmark, in September 2020.

“In a situation with historically high unemployment, we are pleased to offer a solution that can help get more Danes back into the labor force faster. It’s always difficult to be outside the labor force, and even more so if you suffer from stress and depression. “Therefore, we are pleased to offer a solution to municipalities that can help unemployed people suffering with stress and depression get back to work” says CEO Thomas Lethenborg.

“The municipalities are facing a major task due to the increased unemployment we are seeing in the wake of Covid-19. The combination of our services in the psychology and psychiatry services, and Monsenso’s platform to support follow-up and data collection is unique in the market and we are convinced that the service can help municipalities to proactively help the larger group of unemployed ” says Director Camilla Stokholm Bjørkman from Empano. 

To read the Danish version, click here.

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

Monsenso signs agreement to support global pharmaceutical across Europe

Monsenso signs agreement to support global pharmaceutical across Europe

Following a year-long collaboration, Monsenso signs a three-year +10 mio DKK agreement with a global pharmaceutical company.

Monsenso’s mobile health solution will be used for real-world data collection across two studies in connection with the launch of a new drug for depression treatment. The studies are expected to start in the first half of 2021 and will run over a three-year period, covering up to 2250 patients and 120 clinicians across Belgium, the Netherlands, the United Kingdom, Switzerland, Italy, Spain, Denmark, Sweden and France.

In connection with the two studies, Monsenso’s solution will be used to collect data from patients and their relatives through clinical questionnaires, daily self-assessments and behavioral data from smartphones and wearables.

In addition, the patients will be offered in-app study information and can receive reminders about medication and consultations with their clinician. Monsenso’s unique mobile health solution will in this way help increase the quality of clinical studies with real-time data collection while also facilitating better communication between patients, caregivers and clinicians.

“We are very pleased to expand our collaboration with this global pharmaceutical company and to participate in these projects. Depression is a leading burden of disease for society, and it has severe consequences for patients and their family caregivers, so we are proud to contribute to solving this problem” says Thomas Lethenborg, CEO of Monsenso. “In addition, the project will support our European expansion and our focus on partnering with pharmaceuticals, which is in line with our strategy”. 

The project will not affect Monsenso’s previously communicated plans and guidance for the 2020 financial year.

To read the Danish version, click here.

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

Monsenso is ISO 13485 certified

Monsenso is ISO 13485 certified

Quality Policy and Standards

As a technology leader in mobile health (mHealth) solutions for mental health, Monsenso is ISO 13485 certified. ISO 13485 is the gold standard for medical device companies to ensure the quality, safety and efficacy of products in the medical device field. This certification ensures that the product in question, consistently meets customer requirements and regulatory requirements applicable to medical devices and other related services.

Monsenso adheres to the highest security standards. Beyond, being ISO 13485, Monsenso holds the ISO 27001 certifications, a TGA certification and class 1 CE mark.” says Thomas Lethenborg, CEO at Monsenso.

For additional information contact:
Jennifer Highland
Marketing and Communications Manager
Monsenso
+45 81 71 7713
highland@monsenso.com

Monsenso and Empano partner up to help unemployed people get back into the labor force faster

GoGreen research project helps Monsenso enter new markets

GoGreen research project helps Monsenso expanding into new markets. Monsenso is pleased to announce that it is partnering with a pan-European consortium in the Go Green Routes research project supported by the Horizon 2020 programme. The consortium has been granted EUR 10.49 million from the EU to develop innovative solutions that foster mental health and well-being by optimising human-nature interactions for citizens. These innovations will increase the uptake and acceptability of nature-based solutions across the trial cities Burgas, Lahti, Limerick, Tallinn, Umea and Versailles.

Monsenso’s solution will be further developed and used to both encourage green nature-based choices and to monitor citizens’ mental health to help better understand the health impact of nature-based choices for people in cities. Monsenso’s share of the project contribution will be EUR 253.000.

Participating in a project that combines nature-based solutions, green choices and mental health and well-being is very exciting for Monsenso. A lot of focus and investment is going into green solutions and technologies these years, and this could represent a great potential for us. Moreover, the project will expand our international network and help bring the Monsenso solution into new markets”. says Thomas Lethenborg, CEO of Monsenso. 

The project will start in September 2020 and is coordinated by the University of Limerick. The project run for four years and includes 40 partners across 18 countries, among others Mental Health Europe, King’s College London, Technical University Munich, Manchester Metropolitan University and universities in Tallinn, Aachen, Torino, Antwerpen, Versailles and Inland Norway as well as the trial cities.

We envisage that GOGREEN ROUTES will translate cutting edge research into impactful solutions for cities health, mobility and ecology” says Dr Tadhg MacIntyre, lecturer in psychology at the University of Limerick and project lead coordinator.

This project is funded by the European Union’s Horizon 2020 framework programme under grant agreement No 869764.

To read the Danish version, click here.

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

Reference
GOGREEN ROUTES Project Outline, click here.